China Resources Medical Holdings Co., Ltd.
0.26
EUR
+0.00
(-0.76%)
ISIN
KYG2133W1087
CUSIP
G2133W108
Return %
Stock
S&P 500
1Y
-31.77
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Semi-annual Revenue
CNY
•
in mil. unless spec.Semi-annual Earnings Per Share
CNY
•
in mil. unless spec.Semi-annual Dividends Per Share
CNY
•
in mil. unless spec.Company Description
- CEO
- Chuang Zhang
- Full Time Employees
- 19,687
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Kunlun Center Office Building Beijing BE China 100069
- IPO Date
- Nov 29, 2013
- Website
- crmedical.hk
- Similar Companies
- Business
- China Resources Medical Holdings Company Limited operates as an integrated medical and healthcare service provider primarily in China. The company’s core offerings include hospital investment, management, and operation; clinical diagnosis and treatment; healthcare management; and public health services. It manages a comprehensive network of medical institutions comprising general hospitals, specialized hospitals, community health centers, and clinics across major regions including Beijing, North China, East China, Central China, and South China. Its medical facilities include service levels from tertiary to primary care with over 10,000 open beds and annual outpatient and emergency visits exceeding 7.7 million. The company specializes in multi-level healthcare services such as clinical treatment, healthcare management, public health services, and related medical support operations. Recent major developments include significant expansion through acquisition and integration strategies. In 2022, China Resources Medical enhanced its medical service capacity by acquiring 33 high-quality medical institutions, increasing open beds by more than 11,000 and boosting overall service and profit contribution. In August 2024, it entered into strategic cooperation and acquisition agreements with Tasly Pharmaceuticals aiming at innovation in digital traditional Chinese medicine, intelligent manufacturing, R&D, and expanding its industrial investment footprint notably in Tianjin. The company’s growth strategy integrates merger and acquisition activity with capital infusion to strengthen its operational network and service capacities. Additionally, China Resources Medical continues to benefit from its backing by China Resources Group, a major state-owned conglomerate. Founded in 1999 and headquartered in Hong Kong, China Resources Medical Holdings Company Limited leverages its extensive hospital network and healthcare ecosystem across mainland China to offer comprehensive medical services. It is listed on the Hong Kong Stock Exchange under the ticker 1515.HK. The company is positioned in the healthcare industry, targeting broad patient populations and healthcare needs in urban and regional markets. Its expanding portfolio aligns with national healthcare reform trends and rising demand for integrated medical services in China. China Resources Medical thus operates with a strong emphasis on hospital management and healthcare service integration, supported by strategic acquisitions, partnerships in pharmaceutical innovation, and continuous enhancement of healthcare infrastructure and service quality across China.